α-Synuclein and DJ-1 as Potential Biological Fluid Biomarkers for Parkinson’s Disease
Parkinson’s disease (PD) is the most common form of movement disorder and affects approximately 4% of the population aged over 80 years old. Currently, PD cannot be prevented or cured, and no single diagnostic biomarkers are available. Notably, recent studies suggest that two familial PD-linked mole...
Main Authors: | Makoto Hashimoto, Masayo Fujita, Yoshiki Takamatsu, Akio Sekigawa, Kazunari Sekiyama, Masaaki Waragai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/11/11/4257/ |
Similar Items
-
Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies
by: Makoto Hashimoto, et al.
Published: (2012-09-01) -
Increased DJ-1 and α-Synuclein in Plasma Neural-Derived Exosomes as Potential Markers for Parkinson’s Disease
by: Zhen-Hua Zhao, et al.
Published: (2019-01-01) -
Distinct mechanisms of axonal globule formation in mice expressing human wild type α-synuclein or dementia with Lewy bodies-linked P123H ß-synuclein
by: Sekigawa Akio, et al.
Published: (2012-09-01) -
DJ-1 Inhibits α-Synuclein Aggregation by Regulating Chaperone-Mediated Autophagy
by: Chuan-Ying Xu, et al.
Published: (2017-09-01) -
Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies
by: Akio Sekigawa, et al.
Published: (2015-05-01)